Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Shandong stages welcoming event for Europe's Fortune 500 companies 2020-08-31 10:42
New finding - Patient Blood Management delivers cost-effective care 2020-08-28 16:31
GoBroad Healthcare Group Showcases Innovative Hematologic Treatment Capabilities at the China Precision Medicine Forum 2020-08-26 21:00
RoboPharma Acquired by Capsa Healthcare to Broaden Reach Into New Pharmacy Automation Markets 2020-08-26 08:12
CARsgen Therapeutics Receives IND Clearance from the NMPA for CT041 CLDN18.2-CAR-T Cells 2020-08-20 18:32
PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS 2020-08-18 21:00
Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results 2020-08-18 19:00
China Biologic Reports Financial Results for the Second Quarter of 2020 2020-08-18 04:30
I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China 2020-08-17 20:00
WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations 2020-08-13 16:49
Fapon 2nd COVID-19 Donation, 100 Million Anti-SARS-CoV-2 Fully Human RBD IgM & IgG QC Test Materials 2020-08-10 20:00
China Biologic Products to Report Second Quarter 2020 Financial Results 2020-08-10 20:00
VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update 2020-08-10 19:30
Co-Diagnostics, Inc. Logix Smart™ COVID-19 Test Authorized for Use in Australia 2020-08-07 18:30
ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies 2020-08-06 23:49
I-Mab to Report Financial Results for the Six Months Ended June 30, 2020 and Provide Corporate Update on August 31, 2020 2020-08-06 20:30
Samsung Biologics launches S-CHOice cell line expression technology 2020-08-05 09:09
China NMPA Accepts IND Application for Eftansomatropin Pivotal Trial in Pediatric Patients with Growth Hormone Deficiency 2020-08-04 20:17
PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC 2020-08-03 21:00
Seegene Allplex(TM) 2019-nCoV Assay (SARS-CoV-2) Gets Expanded FDA Emergency Use Authorization 2020-07-30 19:00
1 119 120 121 122 123 222